Government bans 16 Fixed Dose Combination (FDC) drugs to ensure patient safety.
The decision follows an expert review by the Drugs Technical Advisory Board (DTAB).
New policy aims to reduce antimicrobial resistance and prevent unnecessary medical toxicity.
Patients are advised to consult doctors for safe, evidence-based individual medication alternatives.